Oncology drug development: what is changing?
Yancey
Mary Ann
MA
National Cancer Institute, Bethesda, MD, USA. yanceym@mail.nih.gov
D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents